Laura Magnano
Universidad de Barcelona
H-index: 22
Europe-Spain
Top articles of Laura Magnano
The academic point‐of‐care anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel (ARI‐0001 cells) shows efficacy and safety in the treatment of relapsed …
British Journal of Haematology
2024/2
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma
Hematological Oncology
2024/1
Julio Delgado
H-Index: 12
Laura Magnano
H-Index: 15
5PSQ-110 Desensitisation to monoclonal antibodies in oncohaematological patients
2024/3/1
Real‐Life Comparison of Antivirals for SARS‐CoV‐2 Omicron Infection in Patients With Hematologic Malignancies
Influenza and Other Respiratory Viruses
2024/3
Laura Magnano
H-Index: 15
Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T‐cell therapy
European Journal of Haematology
2024/3
Laura Magnano
H-Index: 15
Julio Delgado
H-Index: 12
Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review
2023/5/3
Laura Magnano
H-Index: 15
Early progression in follicular lymphoma in the absence of histological transformation or high‐risk Follicular Lymphoma International Prognostic Index still has a favourable …
British Journal of Haematology
2023/2
Laura Magnano
H-Index: 15
Monotherapy with second-generation BCL2 inhibitor sonrotoclax (BGB-11417) is well tolerated with high response rates in patients with relapsed/refractory marginal zone lymphoma …
Blood
2023/11/28
Laura Magnano
H-Index: 15
David Simpson
H-Index: 10
Results of a Second, Prespecified Analysis of the Phase 2 Study ELM-2 Confirm High Rates of Durable Complete Response with Odronextamab in Patients with Relapsed/Refractory (R …
Blood
2023/11/28
Circulating Tumor DNA Analysis Associates with Progression-Free Survival (PFS) with Odronextamab Monotherapy in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and Diffuse …
Blood
2023/11/28
Varnimcabtagene Autoleucel (ARI-0001) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Richter Transformation (RT)
Blood
2023/11/28
Laura Magnano
H-Index: 15
Julio Delgado
H-Index: 12
Maintenance of Moderate to High Levels of Functioning and Quality of Life with Odronextamab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma
Blood
2023/11/28
Impact of Salvage and Bridging Therapy in Adult Patients with Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL) Referred for Anti-CD19 CAR T-Cell Therapy: An Intention to …
Blood
2023/11/28
Laura Magnano
H-Index: 15
Julio Delgado
H-Index: 12
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors
Hematological oncology
2023/10
Julio Delgado
H-Index: 12
Laura Magnano
H-Index: 15
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study
Blood Cancer Journal
2023/9/4
P1394: RITUXIMAB BASED LYMPHODEPLETION MAY INCREASE ENGRAFTMENT AND EFFICACY OF SECOND INFUSIONS OF CART19 CELLS IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.
Hemasphere
2023/8/1
Laura Magnano
H-Index: 15
Julio Delgado
H-Index: 12
P1391: VARNIMCABTAGENE AUTOLEUCEL (VAR-CEL) IN RELAPSED/REFRACTORY CD19+ NON-HODGKIN LYMPHOMA
HemaSphere
2023/8/1
Laura Magnano
H-Index: 15
Julio Delgado
H-Index: 12
IMMUNE PROFILE IN THE PERIPHERAL BLOOD (PB) OF PATIENTS WITH FOLLICULAR LYMPHOMA (FL) AT DIAGNOSIS AND UPON RELAPSE
Hematological Oncology
2023/6
Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World …
Blood
2022/11/15
Laura Magnano
H-Index: 15
Gonzalo Caballero
H-Index: 15
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia
Hematological Oncology
2022/10
Laura Magnano
H-Index: 15
Julio Delgado
H-Index: 12
